Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Silver Continues Upswing, Pushes Above 17.00

Silver continues to its slow-but-sure upward move. The metal posted gains of 2.1% last week and has crossed above the symbolic $17.00 level. Kenny Fisher Silver prices have started the new trading week with g...

Deutsche Telekom, Enthusiast Gaming, Krones - how do insiders act now?

It is generally assumed that the management and supervisory boards of companies have an information advantage over the public and for this reason they are subject to different reporting requirements depending on the stock exchange segment. In practice, this may mean that manag...

Australian Dollar At an Important Juncture

It can be certainly said that AUD/USD has surprised on the upside recently. Having reached several important resistances, and attempting breakout above them, what else can be said about the pair’s current and upcoming performance? Let’s...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia Trial Results Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five instituti...

Time for a Rebound in USD/CAD?

The Canadian dollar has been going from strength to strength recently, but isn’t it time for the greenback to stage a comeback? Let’s examine the story the technicals tell... The first thing that catches the eye on the above chart, is t...

Apellis Pharma Shares Rise 20% on Positive Top-line Data in Phase 3 PNH Trial

Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturna...

The Prospects of USD/CAD Rebound Continuation

The technicals indicated high likelihood of an upswing, and the pair obliged by moving higher recently. Great, but with quite a move behind us already, let’s assess further appreciation potential as it stands right now. Quoting our last commentary on t...

Central Banks’ Gold Buying and Repatriation Spree

Central banks’ purchases and repatriations of gold have caught our attention once again. In October, Serbia’s central bank bought 9 tons of gold , following in the footsteps of many other central banks that have been adding to their gold reserv...

Uranium Major 'Heading Into a Bigger Q4'

The Q3/19 results and the Q4/19 outlook are outlined in a BMO Capital Markets report. In a Nov. 5 research note, BMO Capital Markets analyst Alexander Pearce wrote that following the reporting of Q3/19, the outlook for Cameco Corp. (CCO:TSX; CCJ:NYSE) "remains robus...

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis. Global biopharmaceutical company Insmed Inc. (INSM:NASDAQ) , which is...
1 2 3 4 5 6 7 8 9 10 ...